Facebook
X
LinkedIn
Forward13th International Clinical Cancer Genomics Conference: Accelerating Technology Enabled Precision Oncology
Chicago, IL US
April 23, 2026 to April 25, 2026
Advancements in biomarker and genomic technologies continue to transform cancer care, enabling personalized risk assessment, targeted screening, and precision treatments. As we enter a new era of precision medicine, comprehensive understanding of cancer genomics and the immune microenvironment allows clinicians to identify individuals at the highest risk for lethal, yet treatable, malignancies—thus optimizing surveillance, prevention, and patient outcomes. Landmark achievements, such as the identification of BRCA1 mutation carriers (enabling cancer prevention strategies and PARP inhibitor therapy) and the management of Lynch Syndrome (leading to curative immunotherapeutic approaches for rectal cancer), illustrate the profound impact of genomics on the continuum of care.
We are convening a 3-day in-person conference with 20 world-renowned faculty experts in cancer genomics and over 500 participants with the goal of establishing a Learning Group Network of up to 1000 people at the 13th International Clinical Cancer Genomics Conference—Accelerating Technology Enabled Precision Oncology, where stakeholders will share state-of-the-art science, latest technologies—including Artificial Intelligence—real-world case studies, curated pedigrees, and actionable case summaries. This forum is designed to equip healthcare professionals with practical tools and evidence-based guidelines for managing high-risk patients and their families, with a strong emphasis on technologies that broaden access to biomarker-informed, patient centric precision oncology across the continuum of care from prevention to survivorship.
Target Audience
This activity has been designed for physicians, physician assistants, advanced nurse practitioners, genetic counselors, oncology nurses, pharmacists, and other healthcare professionals currently involved in providing cancer genetics risk assessment services or initiating such services in their health care system. Special efforts will be made to meet the needs of clinicians practicing in non-academic centers and geographically and/or socioeconomically underserved communities.
Learning Objectives
After participating in the activity, participants should be better able to:
- Collaborate with patient advocates to bring patient voices to round table discussions and platform presentations;
- Review advances in genetics, genomics, and next generation Omics technologies transforming precision oncology;
- Evaluate controversies in risk prediction and genomic testing for management decisions, including integration of liquid biopsies into risk adapted treatment;
- Discuss emerging concepts in digital pathology, and integration of Artificial Intelligence in developing Multi-Omics-based biomarkers;
- Develop innovative mentoring platforms for trainees and introduce early Career Researchers to International Genomics focused Consortia such as ENIGMA, and CIMBA;
- Debate ethical implications and opportunities of AI tools in health care.
You may also be interested in
InterContinental Chicago Magnificent Mile by IHG
505 North Michigan Avenue
Chicago, IL
60611
United States
WANT TO KNOW MORE?
Learn more about the program by visiting the conference website! For questions, contact Kristen at Meeting Achievements via e-mail.
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office via e-mail at [email protected].
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
CONFERENCE LEADERSHIP
Olufunmilayo Falusi Olopade, MBBS, FACP
Walter L. Palmer Distinguished Service Professor
Director, Center for Clinical Cancer Genetics
Departments of Medicine and Human Genetics
University of Chicago
Walter L. Palmer Distinguished Service Professor
Director, Center for Clinical Cancer Genetics
Departments of Medicine and Human Genetics
University of Chicago
Kathleen Blazer, EdD, MS, LCGC
Clinical Assistant Professor
Associate Director, Cancer Genomics Education Program
Co-Director, Intensive Course in Cancer Risk Assessment
Co-Investigator, Cancer Genomics Career Development Program
City of Hope National Medical Center
Clinical Assistant Professor
Associate Director, Cancer Genomics Education Program
Co-Director, Intensive Course in Cancer Risk Assessment
Co-Investigator, Cancer Genomics Career Development Program
City of Hope National Medical Center
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 21 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Genetic Counselor Credit
The National Society of Genetic Counselors (NSGC) has authorized University of Chicago Pritzker School of Medicine to offer up to 2.100 CEUs or 21Category 1 contact hours for the activity 13th International Clinical Cancer Genomics Conference. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification.
Nursing Credit
University of Chicago Medicine is accredited as a provider of continuing nursing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Participants who successfully complete the entire activity and complete an evaluation form will earn 21 contact hours.
Participants who successfully complete the entire activity and complete an evaluation form will earn 21 contact hours.
American Board of Internal Medicine MOC Part II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 21 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Other Health Professional Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME, please consult your professional licensing board.
Other Health Professional Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME, please consult your professional licensing board.
Please note: The credit claiming process will close 30 days after the activity ends. Requests to claim credit after 30 days may incur additional fees.
Registration: Click the button below for complete registration information and to register.
REGISTRATION
REGISTRATION
Claiming Credit: After the conference, create or log into your UChicago CME account and enter the access code to unlock the credit claiming process.
Please note: The credit claiming process will close 30 days after the activity ends. Requests to claim credit after 30 days may incur additional fees.
Please login or create an account to proceed.